{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:10:10Z","timestamp":1748059810644,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recent research has indicated an increase in antibiotic utilisation, particularly pediatric formulations. Furthermore, an increasing trend in antimicrobial resistance rates has also been reported. Empirical evidence suggests that immunisation reduces the demand for antibiotics. We examined the potential impact of the periodic intensification of the routine immunisation strategy - Intensified Mission Indradhanush (IMI), which was implemented from October 2017 to January 2018, on antibiotic utilisation in India.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analysed the PharmaTrac dataset to assess the impact of IMI on antibiotic utilisation. We conducted interrupted time series analyses by fitting a Poisson regression model. We used Newey\u2013West standard errors to account for autocorrelation and heteroskedasticity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>Poisson segmented regression analysis showed a 12.6% decrease in Fluoroquinolones sales in the first month of IMI implementation (incidence rate ratio [IRR] 0.874, 95%CI: 0.777\u20130.983). However, post-intervention, their sales remained broadly constant (IRR 1.000, 95%CI 0.995\u20131.006). Similarly, Chloramphenicol sales decreased by 0.6% in the first month, whereas sales increased by a trend of 0.4% per month (IRR 1.004, 95%CI 0.991\u20131.017) post-intervention. Interestingly, Trimethoprim sales increased by 17.1% in the first month but decreased by 0.4% per month (IRR 0.959, 95%CI 0.945\u20130.973) post-intervention. However, there was a modest increase in sales of Macrolides by 3.0%, Cephalosporins by 2.9% and broad-spectrum Penicillin by 0.2% in the first month. Thereafter, Macrolides sales increased by a monthly rate of 0.5% (IRR 1.005, 95% CI 1.000\u20131.010), Cephalosporins increased by 0.5% (IRR 1.005, 95% CI 1.000 -1.010) and Broad spectrum penicillin increased by 0.9% (IRR 1.009, 95% CI 1.004\u20131.013) in the post-intervention period. Furthermore, there were heterogeneities across Indian states.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation<\/jats:title>\n            <jats:p>The IMI\u2019s impact on antibiotic utilisation was heterogeneous across antibiotic classes and Indian states.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11082-3","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:57:05Z","timestamp":1748059025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Did the periodic intensification of routine immunisation strategy (Intensified mission Indradhanush) reduce the demand for pediatric antibiotic formulations in India?"],"prefix":"10.1186","volume":"25","author":[{"given":"Habib Hasan","family":"Farooqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Karan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashna","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giridhara Rathnaiah","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onno C. P.","family":"van Schayck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"10111","key":"11082_CR1","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/S0140-6736(17)32804-0","volume":"390","author":"India State-Level Disease Burden Initiative C","year":"2017","unstructured":"India State-Level Disease Burden Initiative C. Nations within a nation: variations in epidemiological transition across the States of India, 1990\u20132016 in the global burden of disease study. Lancet. 2017;390(10111):2437\u201360.","journal-title":"Lancet"},{"issue":"11","key":"11082_CR2","doi-asserted-by":"publisher","first-page":"e0224848","DOI":"10.1371\/journal.pone.0224848","volume":"14","author":"HH Farooqui","year":"2019","unstructured":"Farooqui HH, Mehta A, Selvaraj S. Outpatient antibiotic prescription rate and pattern in the private sector in India: evidence from medical audit data. PLoS ONE. 2019;14(11):e0224848.","journal-title":"PLoS ONE"},{"issue":"5","key":"11082_CR3","doi-asserted-by":"publisher","first-page":"dlac112","DOI":"10.1093\/jacamr\/dlac112","volume":"4","author":"S Fazaludeen Koya","year":"2022","unstructured":"Fazaludeen Koya S, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Antibiotic consumption in India: geographical variations and Temporal changes between 2011 and 2019. JAC Antimicrob Resist. 2022;4(5):dlac112.","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"11082_CR4","doi-asserted-by":"publisher","first-page":"e001315","DOI":"10.1136\/bmjgh-2018-001315","volume":"4","author":"EY Klein","year":"2019","unstructured":"Klein EY, Tseng KK, Pant S, Laxminarayan R. Tracking global trends in the effectiveness of antibiotic therapy using the drug resistance index. BMJ Glob Health. 2019;4(2):e001315.","journal-title":"BMJ Glob Health"},{"issue":"2","key":"11082_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1377\/hlthaff.2015.1086","volume":"35","author":"S Ozawa","year":"2016","unstructured":"Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in Low- and Middle-Income countries, 2011-20. Health Aff (Millwood). 2016;35(2):199\u2013207.","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"11082_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1377\/hlthaff.2020.00103","volume":"39","author":"SY Sim","year":"2020","unstructured":"Sim SY, Watts E, Constenla D, Brenzel L, Patenaude BN. Return on investment from immunization against 10 pathogens in 94 Low- and Middle-Income countries, 2011-30. Health Aff (Millwood). 2020;39(8):1343\u201353.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"11082_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nyas.14571","volume":"1494","author":"E Schueller","year":"2021","unstructured":"Schueller E, Nandi A, Joshi J, Laxminarayan R, Klein EY. Associations between private vaccine and antimicrobial consumption across Indian States, 2009\u20132017. Ann N Y Acad Sci. 2021;1494(1):31\u201343.","journal-title":"Ann N Y Acad Sci"},{"issue":"51","key":"11082_CR8","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.1073\/pnas.1717157115","volume":"115","author":"DE Bloom","year":"2018","unstructured":"Bloom DE, Black S, Salisbury D, Rappuoli R. Antimicrobial resistance and the role of vaccines. Proc Natl Acad Sci U S A. 2018;115(51):12868\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"11082_CR9","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1073\/pnas.1721095115","volume":"115","author":"KP Klugman","year":"2018","unstructured":"Klugman KP, Black S. Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects. Proc Natl Acad Sci U S A. 2018;115(51):12896\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11082_CR10","doi-asserted-by":"crossref","unstructured":"Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Glob Health 2023, 8(7).","DOI":"10.1136\/bmjgh-2022-011341"},{"key":"11082_CR11","unstructured":"Universal Immunisation Program [https:\/\/main.mohfw.gov.in\/sites\/default\/files\/Universal.pdf]"},{"key":"11082_CR12","doi-asserted-by":"publisher","first-page":"k4782","DOI":"10.1136\/bmj.k4782","volume":"363","author":"V Gurnani","year":"2018","unstructured":"Gurnani V, Haldar P, Aggarwal MK, Das MK, Chauhan A, Murray J, Arora NK, Jhalani M, Sudan P. Improving vaccination coverage in India: lessons from intensified mission Indradhanush, a cross-sectoral systems strengthening strategy. BMJ. 2018;363:k4782.","journal-title":"BMJ"},{"issue":"4","key":"11082_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/heapol\/czab026","volume":"36","author":"E Clarke-Deelder","year":"2021","unstructured":"Clarke-Deelder E, Suharlim C, Chatterjee S, Brenzel L, Ray A, Cohen JL, McConnell M, Resch SC, Menzies NA. Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India. Health Policy Plan. 2021;36(4):454\u201363.","journal-title":"Health Policy Plan"},{"issue":"5","key":"11082_CR14","doi-asserted-by":"publisher","first-page":"e1001826","DOI":"10.1371\/journal.pmed.1001826","volume":"12","author":"P McGettigan","year":"2015","unstructured":"McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing Non-Steroidal Anti-Inflammatory drugs (NSAIDs), Metformin, or psychotropic drugs. PLoS Med. 2015;12(5):e1001826. discussion e1001826.","journal-title":"PLoS Med"},{"key":"11082_CR15","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.lansea.2022.100025","volume":"4","author":"SF Koya","year":"2022","unstructured":"Koya SF, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Consumption of systemic antibiotics in India in 2019. Lancet Reg Health Southeast Asia. 2022;4:100025.","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"3","key":"11082_CR16","doi-asserted-by":"publisher","first-page":"dlaa076","DOI":"10.1093\/jacamr\/dlaa076","volume":"2","author":"HH Farooqui","year":"2020","unstructured":"Farooqui HH, Selvaraj S, Mehta A, Mathur MR. The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008-18. JAC Antimicrob Resist. 2020;2(3):dlaa076.","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"11082_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40545-023-00644-y","volume":"16","author":"P Brhlikova","year":"2023","unstructured":"Brhlikova P, Mehta A, McGettigan P, Pollock AM, Roderick P, Farooqui HH. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics. J Pharm Policy Pract. 2023;16(1):139.","journal-title":"J Pharm Policy Pract"},{"issue":"10","key":"11082_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2471\/BLT.22.287908","volume":"100","author":"A Mehta","year":"2022","unstructured":"Mehta A, Brhlikova P, McGettigan P, Pollock AM, Roderick P, Farooqui HH. Systemic antibiotic sales and WHO recommendations, India. Bull World Health Organ. 2022;100(10):610\u20139.","journal-title":"Bull World Health Organ"},{"key":"11082_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jclinepi.2018.05.026","volume":"103","author":"J Lopez Bernal","year":"2018","unstructured":"Lopez Bernal J, Soumerai S, Gasparrini A. A methodological framework for model selection in interrupted time series studies. J Clin Epidemiol. 2018;103:82\u201391.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"11082_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299\u2013309.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"11082_CR21","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"key":"11082_CR22","volume-title":"National health accounts (NHA) estimates for India for financial year 2015-16. In","author":"MOHFW","year":"2018","unstructured":"MOHFW. National health accounts (NHA) estimates for India for financial year 2015-16. In. New Delhi: NHSRC; 2018."},{"issue":"7806","key":"11082_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","volume":"581","author":"JA Lewnard","year":"2020","unstructured":"Lewnard JA, Lo NC, Arinaminpathy N, Frost I, Laxminarayan R. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature. 2020;581(7806):94\u20139.","journal-title":"Nature"},{"issue":"1","key":"11082_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-023-01272-6","volume":"12","author":"L van Heuvel","year":"2023","unstructured":"van Heuvel L, Paget J, Duckers M, Caini S. The impact of influenza and Pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023;12(1):70.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11082_CR25","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.jvacx.2023.100319","volume":"14","author":"P Dhalaria","year":"2023","unstructured":"Dhalaria P, Kapur S, Singh AK, Verma A, Priyadarshini P, Taneja G. Potential impact of rotavirus vaccination on reduction of childhood diarrheal disease in India: an analysis of National family health Survey-5. Vaccine X. 2023;14:100319.","journal-title":"Vaccine X"},{"issue":"9","key":"11082_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcph.715","volume":"56","author":"K Patel","year":"2016","unstructured":"Patel K, Goldman JL. Safety concerns surrounding quinolone use in children. J Clin Pharmacol. 2016;56(9):1060\u201375.","journal-title":"J Clin Pharmacol"},{"key":"11082_CR27","unstructured":"MOHFW: Intensified Mission Indradhanush Coverage Evaluation Survey. 2018. In. New Delhi: MOHFW; 2019."},{"key":"11082_CR28","doi-asserted-by":"crossref","unstructured":"Kotwani A, Joshi J, Lamkang AS. Over-the-Counter Sale of Antibiotics in India: A Qualitative Study of Providers\u2019 Perspectives across Two States. Antibiot (Basel) 2021, 10(9).","DOI":"10.3390\/antibiotics10091123"},{"issue":"3","key":"11082_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2710.2011.01293.x","volume":"37","author":"A Kotwani","year":"2012","unstructured":"Kotwani A, Wattal C, Joshi PC, Holloway K. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in new Delhi, India. J Clin Pharm Ther. 2012;37(3):308\u201312.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"11082_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/09685332211020786","volume":"21","author":"G Porter","year":"2021","unstructured":"Porter G, Kotwani A, Bhullar L, Joshi J. Over-the-counter sales of antibiotics for human use in India: the challenges and opportunities for regulation. Med Law Int. 2021;21(2):147\u201373.","journal-title":"Med Law Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11082-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:57:08Z","timestamp":1748059028000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11082-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11082"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11082-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was not needed. The study only used anonymised data from secondary sources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}